Ritonavir var den første proteasehæmmer (godkendt i 1996), hvis virkning blev påvist i et forsøg med kliniske effektmål.
Ritonavir was the first protease inhibitor (approved in 1996) for which efficacy was proven in a study with clinical endpoints.